Jingquan Jia

504 citations
28 papers · 246 indexed · h-index 10
Topics
Colorectal Cancer Treatments and Studies (9 papers)Lung Cancer Treatments and Mutations (9 papers)Pancreatic and Hepatic Oncology Research (5 papers)

In The Last Decade

Jingquan Jia

27 papers receiving 242 citations

Peers

Jingquan Jia
Comparison fields: 5 of 50
  • Molecular Biology 116
  • Oncology 114
  • Pulmonary and Respiratory Medicine 58
  • Immunology 51
  • Cancer Research 37
Replace Hideo Tomihara with:
Hideo Tomihara Japan
Youya Nakazawa Japan
Mao Zhang China
Liam Cornell United States
Luke B. Fletcher United States
Gabriel Mak United Kingdom
Nobuhiko Nishijima Japan
Perrine Garde‐Granger Canada
Yusaku Watanabe Japan
Lieve Adriaens United States
Jingquan Jia relative to Hideo Tomihara Japan Hideo Tomihara's profile →
Citations per field
00.5×
Hideo Tomihara · 1×
Citations per year

Countries citing papers authored by Jingquan Jia

Since Specialization
Citations

This map shows the geographic impact of Jingquan Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingquan Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingquan Jia more than expected).

Fields of papers citing papers by Jingquan Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingquan Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingquan Jia. The network helps show where Jingquan Jia may publish in the future.

Co-authorship network of co-authors of Jingquan Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Jingquan Jia. A scholar is included among the top collaborators of Jingquan Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingquan Jia. Jingquan Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 1
4 2
5 11
6 1
7 6
8 1
9 7
10 13
11 17
12 4
13 6
14 6
15 17
16 8
17 36
18 17
19 12
20 23

About Jingquan Jia

Jingquan Jia is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 246 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (114 citations), Hepatology (25 citations) and Cancer Research (37 citations). Jingquan Jia has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Andrew B. Nixon, Yuan Zhuang, Herbert I. Hurwitz, John H. Strickler, Motonari Kondo, Hope E. Uronis, Donna Niedzwiecki, S. Yousuf Zafar, Michael A. Morse and Meifang Dai. Their work appears in journals such as Journal of Clinical Oncology, The EMBO Journal and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026